Impact of hepatitis B virus infection on the risk of gallbladder polyps: a cohort study
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: We aimed to determine whether hepatitis B virus (HBV) or hepatitis C virus (HCV) infection remains an important risk factor for gallbladder polyps (GBPs) in the current context of reduced prevalence of these infections. Methods: The cohort included 392,913 asymptomatic adults who underwent abdominal ultrasonography (US). Results: The prevalence of GBP sized ≥ 5 mm, ≥ 10 mm, and overall (< 5, 5–9 and ≥ 10 mm) was 2.9%, 0.1%, and 12.8%, respectively. The prevalence of hepatitis B surface antigen (HBsAg), hepatitis B core antibody (HBcAb), and hepatitis C antibody (anti-HCV) positivity was 3.2%, 26.7%, and 0.1%, respectively. The GBP risk was significantly increased in HBsAg-positive individuals, with an adjusted odds ratio of 1.66 (95% confidence interval, 1.49–1.85) for GBP ≥ 5 mm, 2.39 (1.53–3.75) for GBP ≥ 10 mm, and 1.49 (1.41–1.59) for overall, whereas there was no significant association between anti-HCV positivity and GBP risk. The GBP risk did not increase significantly in individuals who tested negative for HBsAg but positive for HBcAb. Conclusions: The presence of HBsAg may be an independent risk factor for GBP development in the current context of a indecreasing prevalence of HBsAg positivity. A more comprehensive evaluation of GBP during abdominal US surveillance of HBsAg-positive individuals may be necessary.
Abstract
Background/Aims: We aimed to determine whether hepatitis B virus (HBV) or hepatitis C virus (HCV) infection remains an important risk factor for gallbladder polyps (GBPs) in the current context of reduced prevalence of these infections. Methods: The cohort included 392,913 asymptomatic adults who underwent abdominal ultrasonography (US). Results: The prevalence of GBP sized ≥ 5 mm, ≥ 10 mm, and overall (< 5, 5–9 and ≥ 10 mm) was 2.9%, 0.1%, and 12.8%, respectively. The prevalence of hepatitis B surface antigen (HBsAg), hepatitis B core antibody (HBcAb), and hepatitis C antibody (anti-HCV) positivity was 3.2%, 26.7%, and 0.1%, respectively. The GBP risk was significantly increased in HBsAg-positive individuals, with an adjusted odds ratio of 1.66 (95% confidence interval, 1.49–1.85) for GBP ≥ 5 mm, 2.39 (1.53–3.75) for GBP ≥ 10 mm, and 1.49 (1.41–1.59) for overall, whereas there was no significant association between anti-HCV positivity and GBP risk. The GBP risk did not increase significantly in individuals who tested negative for HBsAg but positive for HBcAb. Conclusions: The presence of HBsAg may be an independent risk factor for GBP development in the current context of a indecreasing prevalence of HBsAg positivity. A more comprehensive evaluation of GBP during abdominal US surveillance of HBsAg-positive individuals may be necessary.
참고문헌 (34)
- Segawa K, "Prevalence of gallbladder polyps among apparently healthy Japanese : ultrasonographic study", Am J Gastroenterol, 87, pp.630~633 (1992)
- 이유진, "Shifting Prevalence of Gallbladder Polyps in Korea", Journal of Korean Medical Science, 29(9), pp.1247~1252 (2014), 대한의학회
- Lee KF, "Polypoid lesions of the gallbladder", Am J Surg, 188, pp.186~190 (2004)
- Kwon OS, "Are there modifiable risk factors affecting the prevalence of gallbladder polyps or those 5 mm or larger? A retrospective cross-sectional study", Medicine(Baltimore), 100, pp.e27115~ (2021)
- Myers RP, "Gallbladder polyps : epidemiology, natural history and management", Can J Gastroenterol, 16, pp.187~194 (2002)
- Yamin Z, "Risk factors of gallbladder polyps formation in East Asian population : a meta-analysis and systematic review", Asian J Surg, 43, pp.52~59 (2020)
- Yang HL, "Analysis of risk factors for polypoid lesions of gallbladder among health examinees", World J Gastroenterol, 18, pp.3015~3019 (2012)
- Ali TA, "Prevalence and risk factors of gallbladder polyps in primary health care centers among patients examined by abdominal ultrasonography in Qatar : a case-control study", Qatar Med J, 2021, pp.48~ (2021)
- Lin WR, "Prevalence of and risk factors for gallbladder polyps detected by ultrasonography among healthy Chinese : analysis of 34 669 cases", J Gastroenterol Hepatol, 23, pp.965~969 (2008)
- 박은정, "Association between Metabolic Syndrome and Gallbladder Polyps in Healthy Korean Adults", Journal of Korean Medical Science, 28(6), pp.876~880 (2013), 대한의학회
- Xu Q, "Prevalences of and risk factors for biliary stones and gallbladder polyps in a large Chinese population", HPB(Oxford), 14, pp.373~381 (2012)
- Mao YS, "Prevalence and risk factors of gallbladder polypoid lesions in Chinese petrochemical employees", World J Gastroenterol, 19, pp.4393~4399 (2013)
- 도재혁, "Prevalence and Risk Factors of Gallbladder Polypoid Lesions in a Healthy Population", Yonsei Medical Journal, 57(6), pp.1370~1375 (2016), 연세대학교의과대학[DOI]
- Chen CY, "Risk factors for gallbladder polyps in the Chinese population", Am J Gastroenterol, 92, pp.2066~2068 (1997)
- Seon Hee Lim, "Is Metabolic Syndrome One of the Risk Factors for Gallbladder Polyps Found by Ultrasonography during Health Screening?", Gut and Liver, 1(2), pp.138~144 (2007), 거트앤리버 소화기연관학회협의회
- Chang TS, "Hepatitis C virus infection facilitates gallstone formation", J Gastroenterol Hepatol, 20, pp.1416~1421 (2005)
- Lai SW, "Risk factors for gallstone disease in a hospital-based study", South Med J, 95, pp.1419~1423 (2002)
- Chang Y, "Metabolically Healthy obesity and development of chronic kidney disease : a cohort study", Ann Intern Med, 164, pp.305~312 (2016)
- Chang Y, "Alcoholic and nonalcoholic fatty liver disease and liver-related mortality : a cohort study", Am J Gastroenterol, 114, pp.620~629 (2019)
- Craig CL, "International physical activity questionnaire : 12-country reliability and validity", Med Sci Sports Exerc, 35, pp.1381~1395 (2003)
- Wen CP, "Are Asians at greater mortality risks for being overweight than Caucasians? Redefining obesity for Asians", Public Health Nutr, 12, pp.497~506 (2009)
- Collett JA, "Gallbladder polyps : prospective study", J Ultrasound Med, 17, pp.207~211 (1998)
- Hong CY, "Incidence of extrahepatic cancers among individuals with chronic hepatitis B or C virus infection : a nationwide cohort study", J Viral Hepat, 27, pp.896~903 (2020)
- Liu T, "Hepatitis B virus infection and the risk of gastrointestinal cancers among Chinese population : a prospective cohort study", Int J Cancer, 150, pp.1018~1028 (2022)
- Tan YJ, "Hepatitis B virus infection and the risk of hepatocellular carcinoma", World J Gastroenterol, 17, pp.4853~4857 (2011)
- Arzumanyan A, "Pathogenic mechanisms in HBV-and HCV-associated hepatocellular carcinoma", Nat Rev Cancer, 13, pp.123~135 (2013)
- Jun Kyu Lee, "Visceral Obesity Is Associated with Gallbladder Polyps", Gut and Liver, 10(1), pp.133~139 (2016), 거트앤리버 소화기연관학회협의회
- 임선영, "The epidemiology of hepatitis B virus infection in Korea", The Korean Journal of Internal Medicine, 34(5), pp.945~953 (2019), 대한내과학회[DOI]
- 김보현, "Epidemiology of liver cancer in South Korea", Clinical and Molecular Hepatology, 24(1), pp.1~9 (2018), 대한간학회
- Yoon Jung-Hwan, "Epidemiological and Clinical History of Viral Hepatitis in Korea", Infection and Chemotherapy, 53(1), pp.159~165 (2021), 대한감염학회[DOI]
- Ahn DW, "Fatty liver is an independent risk factor for gallbladder polyps", World J Gastroenterol, 26, pp.6979~6992 (2020)
- Kwak MS, "Occult hepatitis B virus infection", World J Hepatol, 6, pp.860~869 (2014)
- 권우일, "Clinicopathologic Features of Polypoid Lesions of the Gallbladder and Risk Factors of Gallbladder Cancer", Journal of Korean Medical Science, 24(3), pp.481~487 (2009), 대한의학회
- Yu Z, "Risk factors for cholesterol polyp formation in the gallbladder are closely related to lipid metabolism", Lipids Health Dis, 20, pp.26~ (2021)